Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
10771770 | Biochemical and Biophysical Research Communications | 2005 | 6 Pages |
Abstract
Gene therapy has attracted attention as a potentially effective alternative to liver transplantation for the treatment of hepatic failure. We chose the C/EBPβ gene, which plays vital roles in liver regeneration, as a candidate for gene therapy, and examined its effect on hepatocyte survival and the suppression of liver inflammation. C/EBPβ gene overexpression significantly maintained hepatocyte viability during 12 days of the culture. Urea synthesis ability, which is a liver-specific function, in Adv-C/EBPβ-infected hepatocytes was stably maintained during the culture, but the activity per cell was significantly lower than that in non-infected cells. On the contrary, DNA synthesis activity in Adv-C/EBPβ-infected hepatocytes was significantly higher than that in non-infected cells. COX-2 was induced in Adv-C/EBPβ-infected hepatocytes, and the addition of NS398, a specific inhibitor of COX-2, suppressed the viability-maintenance effect. COX-2 was thus shown to be involved in the survival effect of C/EBPβ gene. The introduction of the C/EBPβ gene into liver-damaged mice significantly suppressed the serum AST and ALT activities. These results indicate that C/EBPβ appears to be a survival factor under stressful conditions, and the introduction of the gene has therapeutic function against liver injury.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Biochemistry
Authors
Katsuhiro Isoda, Hiroko Koide, Midori Kojima, Eri Arita, Masahiro Ikkaku, Shinji Higashiyama, Fumi Tashiro, Eiji Yamato, Jun-Ichi Miyazaki, Masaya Kawase, Kiyohito Yagi,